Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
Regulation BioPharmaceutical Medical Device

Maureen Kenny, 1963-2022

  • Obituary

Executive Summary

Kenny, a mainstay of our publications for three decades, has passed away in London.

You may also be interested in...



Pink Sheet’s Top Seven Infographics Of 2022

From US drug pricing to Japan’s Sakigake expedited pathway, important regulatory developments and trends are easier to understand and track with Pink Sheet graphics.

Maureen Kenny, 1963-2022

Kenny, a mainstay of our publications for three decades, has passed away in London.

Maureen Kenny, 1963-2022

Kenny, a mainstay of our publications for three decades, has passed away in London.

Table

View full table

Topics

Tags:
Regulation BioPharmaceutical Medical Device
Latest Headlines

Risk/Benefit Of CAR-T For Autoimmune Diseases May Shift With FDA Investigation

Who Will Emerge As Best In Class Of The FGF21 Analogs In NASH?

CAR-T Safety Probe Causes Alarm, But Is Unlikely To Upend Therapies

Stock Watch: Is Oncology Still King?

See All
UsernamePublicRestriction

Register

SC146841

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By